Results 171 to 180 of about 76,424 (294)
A Chitosan–Carbon Nanotube‐Modified Microelectrode for In Situ Detection of Blood Levels of the Antipsychotic Clozapine in a Finger‐Pricked Sample Volume [PDF]
Rajendra P. Shukla, Hadar Ben‐Yoav
openalex +1 more source
This study demonstrates the protective effect of acute restraint stress (ARS) against hepatic ischemia–reperfusion injury (HIRI) in mice and investigates its specific neuroendocrine mechanisms. During ARS, excitability of PVNCRH neurons significantly increases, which drives HPA axis to release corticosterone, thereby reducing hepatic inflammation and ...
Xiaoqi Lin +12 more
wiley +1 more source
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan +6 more
wiley +1 more source
Pharmacological Advances in Clozapine Treatment: A Comprehensive Review [PDF]
N Madhanraj, Santhoshkumar Santhoshkumar
openalex +1 more source
ABSTRACT Intestinal health could be affected by intestinal motility, which is controlled by the enteric nervous system. In this study, we found that α‐ketoglutarate (AKG) inhibits intestinal motility and improves intestinal permeability, accompanied by an increased count of intestinal flora.
Guli Xu +9 more
wiley +1 more source
COVID‐19 Infection Changed P300 Latency in Patients With Psychosis: A Retrospective Cohort Study
ABSTRACT Background and Aims The COVID‐19 pandemic raises concerns about neurological impacts on individuals with mental health conditions, particularly cognitive function. P300 event‐related potential (ERP) latency is a validated neurophysiological marker of attention and working memory.
Xiaofeng Jiang +4 more
wiley +1 more source
Antipsychotic treatment in schizophrenia: balancing relapse prevention and functional recovery
Jan P. A. M. Bogers
doaj +1 more source
ABSTRACT Background The paliperidone palmitate 3‐month (PP3M) formulation offers an extended dosing interval compared to the 1‐month (PP1M) formulation. However, data on the comparative side effect profiles of PP1M versus PP3M in real‐world settings remain limited.
Erkan Kuru +3 more
wiley +1 more source
Clozapine, agranulocytosis, and benign ethnic neutropenia [PDF]
Sundararajan Rajagopal
openalex +1 more source

